AI English summary of an SEC filing — figures as filed
Ulta Beauty ULTAUlta Beauty said net sales for the 13-week period ended August 3, 2024 (Q2) rose to $2,552.1 million from $2,529.8 million a year earlier, a 0.9% increase, while comparable sales fell 1.2%. The company cited a 1.8% decline in transactions as the factor behind the drop in comparable sales, and said average ticket rose 0.6%.
Key points
AI summaryUlta Beauty said net sales for the 13-week period ended August 3, 2024 (Q2) rose to $2,552.1 million from $2,529.8 million a year earlier, a 0.9% increase, while comparable sales fell 1.2%. The company cited a 1.8% decline in transactions as the factor behind the drop in comparable sales, and said average ticket rose 0.6%.
The company said gross margin for Q2 fell to 38.3% from 39.3% a year earlier, and operating margin fell to 12.9% from 15.5%. It said net income was $252.6 million and diluted earnings per share were $5.30, down from $300.1 million and $6.02 a year earlier.
The company said it changed its full-year fiscal 2024 net sales outlook to $11.0 billion to $11.2 billion from $11.5 billion to $11.6 billion, and its diluted earnings per share outlook to $22.60 to $23.50 from $25.20 to $26.00. Its comparable sales outlook moved to (2%) to 0% from 2% to 3%, and its operating margin outlook moved to 12.7% to 13.0% from 13.7% to 14.0%.
The company said it repurchased 549,852 shares for $212.3 million during Q2. It said that as of August 3, 2024, $1.6 billion remained of the $2.0 billion program. On the same date, cash and cash equivalents were $414.0 million, and merchandise inventories were $2.0 billion, up 10.1% from a year earlier.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q2 Net Sales and Comparable Sales
Ulta Beauty said net sales for the 13-week period ended August 3, 2024 (Q2) rose to $2,552.1 million from $2,529.8 million a year earlier, a 0.9% increase, while comparable sales fell 1.2%. The company cited a 1.8% decline in transactions as the factor behind the drop in comparable sales, and said average ticket rose 0.6%.
Source · Based on the filing body and exhibits
Q2 Margins and Earnings Per Share
The company said gross margin for Q2 fell to 38.3% from 39.3% a year earlier, and operating margin fell to 12.9% from 15.5%. It said net income was $252.6 million and diluted earnings per share were $5.30, down from $300.1 million and $6.02 a year earlier.
Source · Based on the filing body and exhibits
Full-Year Outlook Changes
The company said it changed its full-year fiscal 2024 net sales outlook to $11.0 billion to $11.2 billion from $11.5 billion to $11.6 billion, and its diluted earnings per share outlook to $22.60 to $23.50 from $25.20 to $26.00. Its comparable sales outlook moved to (2%) to 0% from 2% to 3%, and its operating margin outlook moved to 12.7% to 13.0% from 13.7% to 14.0%.
Source · Based on the filing body and exhibits
Share Repurchases, Cash and Inventory
The company said it repurchased 549,852 shares for $212.3 million during Q2. It said that as of August 3, 2024, $1.6 billion remained of the $2.0 billion program. On the same date, cash and cash equivalents were $414.0 million, and merchandise inventories were $2.0 billion, up 10.1% from a year earlier.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…